Clinical Trials Directory

Trials / Completed

CompletedNCT00081341

Cognition, Steroids, and Imaging in Cushings Disease

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
9 Years
Healthy volunteers
Accepted

Summary

This study investigates the effects of the glucocorticoid hormone cortisol on brain structure and function. Patients with Cushing's disease are studied before and after treatment. Brain imaging and neuropsychologic tests are used to study changes in the hippocampus and thinking and learning functions as well as mood during the period of elevated cortisol. At several intervals after treatment, these are reexamined to study the degree of reversibility of the abnormalities. The contribution of cortisol as well as testosterone and estrogen to dysfunction and recovery is studied. Since elevated cortisol and dysregulation of its secretory system occurs in a significant proportion of the aged and in Alzheimers Disease and Major Depressive Disorder, these studies will help advance knowledge of the role of cortisol in these conditions.

Conditions

Timeline

Completion
2002-12-01
First posted
2004-04-12
Last updated
2010-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00081341. Inclusion in this directory is not an endorsement.

Cognition, Steroids, and Imaging in Cushings Disease (NCT00081341) · Clinical Trials Directory